351 related articles for article (PubMed ID: 19121297)
41. Biochemical studies on a variant of branched chain ketoaciduria in a 19-year-old female.
Fischer MH; Gerritsen T
Pediatrics; 1971 Nov; 48(5):795-801. PubMed ID: 5125877
[No Abstract] [Full Text] [Related]
42. Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.
Schönberger S; Schweiger B; Schwahn B; Schwarz M; Wendel U
Mol Genet Metab; 2004 May; 82(1):69-75. PubMed ID: 15110325
[TBL] [Abstract][Full Text] [Related]
43. Maple syrup urine disease (branched-chain keto-aciduria) variant type manifesting as hyperkinetic behaviour and mental retardation. Report of two cases.
Kalyanaraman K; Chamukuttan S; Arjundas G; Gajanan N; Ramamurthi B
J Neurol Sci; 1972 Feb; 15(2):209-17. PubMed ID: 5010106
[No Abstract] [Full Text] [Related]
44. Cigarette smoke induced oxidative insult in local population of Pokhara.
Jha JC; Maharjan BR; Adhikari D; Vishwanath P; Akila ; Nagamma T; Azhari S; Singh PP
Kathmandu Univ Med J (KUMJ); 2007; 5(4):511-7. PubMed ID: 18604085
[TBL] [Abstract][Full Text] [Related]
45. Alterations in plasma-free amino acids in dogs with hepatic insufficiency.
Iob V; Mattson WJ; Sloan M; Coon WW; Turcotte JG; Child CG
Surg Gynecol Obstet; 1970 May; 130(5):794-800. PubMed ID: 5440765
[No Abstract] [Full Text] [Related]
46. Anorexia and plasma levels of free tryptophan, branched chain amino acids, and ghrelin in hemodialysis patients.
Bossola M; Scribano D; Colacicco L; Tavazzi B; Giungi S; Zuppi C; Luciani G; Tazza L
J Ren Nutr; 2009 May; 19(3):248-55. PubMed ID: 19243975
[TBL] [Abstract][Full Text] [Related]
47. Erythrocyte glutathione peroxidase activity and plasma selenium concentration are reduced in maple syrup urine disease patients during treatment.
Barschak AG; Sitta A; Deon M; Barden AT; Schmitt GO; Dutra-Filho CS; Wajner M; Vargas CR
Int J Dev Neurosci; 2007 Aug; 25(5):335-8. PubMed ID: 17574789
[TBL] [Abstract][Full Text] [Related]
48. Exposure to leucine induces oxidative stress in the brain of zebrafish.
de Medeiros BZ; Wessler LB; Duarte MB; Lemos IS; Candiotto G; Canarim RO; Dos Santos PCL; Torres CA; Scaini G; Rico EP; Generoso JS; Streck EL
Metab Brain Dis; 2022 Apr; 37(4):1155-1161. PubMed ID: 35275349
[TBL] [Abstract][Full Text] [Related]
49. [Leucinosis: study of a case].
Moura-Ribeiro MV; Funayama CA
Arq Neuropsiquiatr; 1985 Dec; 43(4):403-6. PubMed ID: 3833142
[TBL] [Abstract][Full Text] [Related]
50. Peripheral metabolism of branched-chain keto acids in patients with chronic renal failure.
Garibotto G; Paoletti E; Fiorini F; Russo R; Robaudo C; Deferrari G; Tizianello A
Miner Electrolyte Metab; 1993; 19(1):25-31. PubMed ID: 8345831
[TBL] [Abstract][Full Text] [Related]
51. Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease.
Scaini G; Teodorak BP; Jeremias IC; Morais MO; Mina F; Dominguini D; Pescador B; Comim CM; Schuck PF; Ferreira GC; Quevedo J; Streck EL
Behav Brain Res; 2012 May; 231(1):92-6. PubMed ID: 22433584
[TBL] [Abstract][Full Text] [Related]
52. Determination of branched chain amino acids, methionine, phenylalanine, tyrosine and alpha-keto acids in plasma and dried blood samples using HPLC with fluorescence detection.
Kand'ár R; Záková P; Jirosová J; Sladká M
Clin Chem Lab Med; 2009; 47(5):565-72. PubMed ID: 19290779
[TBL] [Abstract][Full Text] [Related]
53. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation.
Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE
Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474
[No Abstract] [Full Text] [Related]
54. Variant maple syrup urine disease in mother and daughter.
Zaleski LA; Dancis J; Cox RP; Hutzler J; Zaleski WA; Hill A
Can Med Assoc J; 1973 Aug; 109(4):299-300 passim. PubMed ID: 4730202
[TBL] [Abstract][Full Text] [Related]
55. Urinary biomarkers of oxidative damage in Maple syrup urine disease: the L-carnitine role.
Guerreiro G; Mescka CP; Sitta A; Donida B; Marchetti D; Hammerschmidt T; Faverzani J; Coelho Dde M; Wajner M; Dutra-Filho CS; Vargas CR
Int J Dev Neurosci; 2015 May; 42():10-4. PubMed ID: 25680940
[TBL] [Abstract][Full Text] [Related]
56. [Behavior of free amino acids in the blood of leukemia patients following amino acid infusion].
Stacher A; Stöckl W; Zacherl MK; Weiser M
Wien Med Wochenschr; 1968 Nov; 118(48):1032-40. PubMed ID: 5250545
[No Abstract] [Full Text] [Related]
57. Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises.
Wajner M; Coelho DM; Barschak AG; Araújo PR; Pires RF; Lulhier FL; Vargas CR
J Inherit Metab Dis; 2000 Jul; 23(5):505-12. PubMed ID: 10947205
[TBL] [Abstract][Full Text] [Related]
58. Diagnosis of maple syrup urine disease by determination of L-valine, L-isoleucine, L-leucine and L-phenylalanine in neonatal blood spots by gas chromatography-mass spectrometry.
Deng C; Deng Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(2):261-8. PubMed ID: 12860033
[TBL] [Abstract][Full Text] [Related]
59. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts.
Skaper SD; Molden DP; Seegmiller JE
Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377
[TBL] [Abstract][Full Text] [Related]
60. Electroencephalograms in a case of maple syrup urine disease: their relation to serum levels of branched-chain amino acids.
Iinuma K; Saito T; Wada Y; Onuma A; Takamatsu N
Tohoku J Exp Med; 1976 Oct; 120(2):191-5. PubMed ID: 982436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
